Sight Sciences, Inc. (SGHT)
8.26
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 19, 16:00
8.26
0.00 (0.00%)
After-Hours: 17:48
Sight Sciences Enterprise Value : 415.27M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 415.27M |
| October 15, 2026 | 443.72M |
| October 14, 2026 | 413.63M |
| October 13, 2026 | 421.29M |
| October 12, 2026 | 452.75M |
| October 09, 2026 | 448.65M |
| October 08, 2026 | 425.67M |
| October 07, 2026 | 425.67M |
| October 06, 2026 | 430.59M |
| October 05, 2026 | 450.29M |
| October 02, 2026 | 428.95M |
| October 01, 2026 | 456.31M |
| September 30, 2026 | 474.37M |
| September 29, 2026 | 473.82M |
| September 28, 2026 | 469.44M |
| September 25, 2026 | 450.84M |
| September 24, 2026 | 437.16M |
| September 23, 2026 | 427.31M |
| September 22, 2026 | 432.23M |
| September 21, 2026 | 426.76M |
| September 18, 2026 | 401.05M |
| September 17, 2026 | 404.33M |
| September 16, 2026 | 407.61M |
| September 15, 2026 | 405.97M |
| September 14, 2026 | 407.06M |
| Date | Value |
|---|---|
| September 11, 2026 | 407.61M |
| September 10, 2026 | 400.22M |
| September 09, 2026 | 402.69M |
| September 08, 2026 | 405.42M |
| September 04, 2026 | 419.10M |
| September 03, 2026 | 420.74M |
| September 02, 2026 | 422.93M |
| September 01, 2026 | 410.35M |
| August 31, 2026 | 427.31M |
| August 28, 2026 | 430.05M |
| August 27, 2026 | 422.39M |
| August 26, 2026 | 420.20M |
| August 25, 2026 | 417.46M |
| August 24, 2026 | 420.74M |
| August 21, 2026 | 414.18M |
| August 20, 2026 | 408.16M |
| August 19, 2026 | 425.67M |
| August 18, 2026 | 411.99M |
| August 17, 2026 | 413.08M |
| August 14, 2026 | 407.61M |
| August 13, 2026 | 417.46M |
| August 12, 2026 | 415.27M |
| August 11, 2026 | 386.27M |
| August 10, 2026 | 383.54M |
| August 07, 2026 | 370.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Integra LifeSciences Holdings Corp. | 2.802B |
| Abbott Laboratories | 209.16B |
| AngioDynamics, Inc. | 453.62M |
| Alphatec Holdings, Inc. | 2.106B |
| AtriCure, Inc. | 2.758B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.446M |
| Revenue (Quarterly) | 23.39M |
| Total Expenses (Quarterly) | 27.83M |
| EPS Diluted (Quarterly) | -0.0816 |
| Gross Profit Margin (Quarterly) | 91.39% |
| Profit Margin (Quarterly) | -19.01% |
| Earnings Yield | -6.74% |
| Normalized Earnings Yield | -6.738 |